LYSSAVIRUS ANTIGEN CONSTRUCTS

Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.

Saved in:
Bibliographic Details
Main Authors SAMSA, MARCELO, YU, DONG, STOKES, ALAN, MALYALA, PADMA, SLACK, OLGA, HASHEY, KATHRYN, JALAH, RASHMI
Format Patent
LanguageEnglish
Published 04.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
Bibliography:Application Number: US202217591421